Vencore Inc

Brian F. Smith & Associates (BFSA) is a distinguished firm based in Poway, California, specializing in various environmental and archaeological services. Their extensive project portfolio includes collaborations with notable entities such as the San Diego Padres for the PETCO Park development and various projects across Southern California and beyond. With expertise in archaeology, history, paleontology, and biology, BFSA addresses diverse environmental assessments and restoration efforts. Their commitment to preserving historical sites and promoting ecological stewardship is evident in their work across a wide range of projects, including municipal developments and significant public works initiatives. Generated from the website

Laguna Mountain Environmental, Inc. is a well-established archaeological consulting firm based in San Diego, CA, offering comprehensive cultural resource services to private, commercial, and government clients. With over 40 years of experience, the company is committed to producing high-quality scientific documents, conducting thorough technical analyses, and ensuring regulatory compliance. Specializing in the identification, evaluation, and management of archaeological, ethnographic, and historic resources, Laguna Mountain has successfully completed over 500 diverse cultural resource studies in the southern California region. Their team of experienced professionals works closely with clients, Native American groups, and government agencies to deliver exceptional satisfaction for every project.Generated from the website

Cenna Biosciences, LLC, based in La Jolla, California, is a biopharmaceutical company dedicated to developing innovative treatments for Alzheimer's disease. Their lead product, Nubytide, is a potential disease-modifying peptide offering a proactive therapy aimed at preventing and treating Alzheimer's, targeting inflammation and Tau pathology in the brain. With a strong intellectual property portfolio and significant market potential, Cenna aims to make Nubytide accessible to every patient suffering from Alzheimer's disease. The company has received a Phase II SBIR grant from the National Institutes of Health to support the early clinical development of Nubytide, highlighting its commitment to addressing the growing global Alzheimer's epidemic. Generated from the website